1. Home
  2. SDHC vs EVO Comparison

SDHC vs EVO Comparison

Compare SDHC & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SDHC
  • EVO
  • Stock Information
  • Founded
  • SDHC 2008
  • EVO 1993
  • Country
  • SDHC United States
  • EVO Germany
  • Employees
  • SDHC N/A
  • EVO N/A
  • Industry
  • SDHC
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • SDHC
  • EVO Health Care
  • Exchange
  • SDHC Nasdaq
  • EVO Nasdaq
  • Market Cap
  • SDHC 933.4M
  • EVO 1.5B
  • IPO Year
  • SDHC 2024
  • EVO 2021
  • Fundamental
  • Price
  • SDHC $19.98
  • EVO $4.08
  • Analyst Decision
  • SDHC Hold
  • EVO Buy
  • Analyst Count
  • SDHC 4
  • EVO 2
  • Target Price
  • SDHC $23.63
  • EVO $5.90
  • AVG Volume (30 Days)
  • SDHC 101.3K
  • EVO 117.0K
  • Earning Date
  • SDHC 08-13-2025
  • EVO 08-13-2025
  • Dividend Yield
  • SDHC N/A
  • EVO N/A
  • EPS Growth
  • SDHC N/A
  • EVO N/A
  • EPS
  • SDHC 0.24
  • EVO N/A
  • Revenue
  • SDHC $1,010,976,000.00
  • EVO $851,944,444.00
  • Revenue This Year
  • SDHC $3.34
  • EVO $10.08
  • Revenue Next Year
  • SDHC $10.22
  • EVO $10.99
  • P/E Ratio
  • SDHC $83.11
  • EVO N/A
  • Revenue Growth
  • SDHC 28.67
  • EVO 1.50
  • 52 Week Low
  • SDHC $16.28
  • EVO $2.84
  • 52 Week High
  • SDHC $39.50
  • EVO $5.64
  • Technical
  • Relative Strength Index (RSI)
  • SDHC 63.47
  • EVO 57.98
  • Support Level
  • SDHC $18.90
  • EVO $4.15
  • Resistance Level
  • SDHC $21.77
  • EVO $4.35
  • Average True Range (ATR)
  • SDHC 1.02
  • EVO 0.11
  • MACD
  • SDHC 0.27
  • EVO 0.03
  • Stochastic Oscillator
  • SDHC 82.08
  • EVO 98.39

About SDHC Smith Douglas Homes Corp.

Smith Douglas Homes Corp is a company engaged in the design, construction, and sale of single-family homes in some of the highest growth and desirable markets in the Southeastern United States. It is organized into eight geographical divisions which comprise two reportable segments. Its Southeast segment consists of Atlanta, Central Georgia, Charlotte, Greenville, and Raleigh divisions. Its Central segment consists of Alabama, Houston, and Nashville divisions.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: